Review
doi: 10.12968/hosp.1999.60.8.1175.
Levomepromazine (methotrimeprazine) and the last 48 hours
Affiliations
- PMID: 10621810
- DOI: 10.12968/hosp.1999.60.8.1175
Item in Clipboard
Review
Levomepromazine (methotrimeprazine) and the last 48 hours
Hosp Med.
1999 Aug.
Abstract
Levomepromazine (previously known as methotrimeprazine) has a broad range of beneficial effects in the terminal phase of many illnesses, resulting from its combined antipsychotic, anxiolytic and sedative actions. Levomepromazine can safely be administered in a continuous subcutaneous infusion with most other commonly used drugs in palliative care.
Similar articles
-
Little effects of low dosage of levomepromazine on plasma risperidone levels.Pharmacopsychiatry. 2005 Mar;38(2):98-100. doi: 10.1055/s-2005-837811. Pharmacopsychiatry. 2005. PMID: 15744635
-
How is agitation and restlessness managed in the last 24 h of life in patients whose care is supported by the Liverpool care pathway for the dying patient?BMJ Support Palliat Care. 2011 Dec;1(3):329-33. doi: 10.1136/bmjspcare-2011-000075. BMJ Support Palliat Care. 2011. PMID: 24653479
-
Levomepromazine for schizophrenia.Schizophr Bull. 2012 Mar;38(2):219-20. doi: 10.1093/schbul/sbr174. Epub 2011 Nov 23. Schizophr Bull. 2012. PMID: 22114097 Free PMC article. Review. No abstract available.
-
Focus on levomepromazine.Curr Med Res Opin. 2004 Dec;20(12):1877-81. doi: 10.1185/030079904X12708. Curr Med Res Opin. 2004. PMID: 15701205 Review.
-
'Palliative sedation'? A retrospective cohort study on the use and labelling of continuously administered sedatives on a palliative care unit.Palliat Med. 2018 Jul;32(7):1189-1197. doi: 10.1177/0269216318764095. Epub 2018 Mar 20. Palliat Med. 2018. PMID: 29557260
Cited by
-
How Do Liquid-Junction Potentials and Medium Polarity at Electrode Surfaces Affect Electrochemical Analyses for Charge-Transfer Systems?J Phys Chem B. 2023 Feb 16;127(6):1443-1458. doi: 10.1021/acs.jpcb.2c07983. Epub 2023 Feb 3. J Phys Chem B. 2023. PMID: 36735861 Free PMC article.